Search

Your search keyword '"Alp, Alpaslan"' showing total 218 results

Search Constraints

Start Over You searched for: Author "Alp, Alpaslan" Remove constraint Author: "Alp, Alpaslan"
218 results on '"Alp, Alpaslan"'

Search Results

5. COVID-19'UN BULAŞMA İLE İLGİLİ ÖZELLİKLERİ: PROSPEKTİF HANEHALKI ARAŞTIRMASI.

7. A case‐control study of the effects of Aspergillus clinical phenotypes on pulmonary functions in patients with cystic fibrosis

11. Immunogenicity of two doses of inactive COVID ‐19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapy

13. Sensitivity Affected by Disease Severity and Serum Sampling Time: a Performance Evaluation of Six SARS-CoV-2 Antibody Immunoassays

15. A screening study for COVID ‐19‐associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic

16. Hacettepe Sağlık Kohortu (HU-CoVaCS): Çalışma Tasarımı, Başlangıç Viziti Değerlendirmesi ve COVID-19 Aşılıların İlk Üç Aylık Takip Verileri.

17. Immunogenicity of two doses of inactive COVID‐19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapy.

22. Respiratory Tract Pathogens in the COVID-19 Era: Data from a Pediatric Emergency Department

24. Human Ace D/I Polymorphism Could Affect the Clinicobiological Course of COVID-19

25. Surveillance for invasive pulmonary aspergillosis in critically ill patients with COVID-19

27. Mapping of serological testing and SARS-CoV-2 seroprevalence studies performed in 20 European countries, March-June 2020

34. Outcome of noncritical COVID-19 patients with early hospitalization and early antiviral treatment outside the ICU

37. The Frequency and Related Factors of Non‐Tuberculosis Mycobacteria Infections among Patients with Cystic Fibrosis

38. The association of viral load and disease severity in children with COVID‐19

40. Hepatitis E virus seroprevalence and associated risk factors in high-risk groups: A cross-sectional study from Turkey

41. Pneumococcal carriage in children with COVID-19

42. Clinical features and outcomes of COVID‐19 in patients with solid tumors: Turkish National Registry Data

44. Evaluation of 2015-2016 MOTAKK HBV DNA and HCV RNA External Quality Assessment National Program Results

45. A COVID-19 first evaluation clinic at a university hospital in Turkey.

46. Human bocavirus and human metapneumovirus in children with lower respiratory tract infections: Effects on clinical, microbiological features and disease severity.

47. Multicentric Castleman disease in a DOCK8‐deficient patient with Orf virus infection.

49. Clinical features and outcomes of COVID-19 in patients with solid tumors: Turkish National Registry Data.

50. Helicobacter pylori Tanısında Kültür, Real-Time-PCR, Elisa ve Histopatolojik İnceleme Yöntemlerinin Karşılaştırılması

Catalog

Books, media, physical & digital resources